{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:27:08Z","timestamp":1786595228963,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.humpath.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T12:43:52Z","timestamp":1695386632000},"page":"158-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["LRP1B\u2014a prognostic marker in tubo-ovarian high-grade serous carcinoma"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4884-0605","authenticated-orcid":false,"given":"Svenja","family":"Kolb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna","family":"Monj\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihnea P.","family":"Dragomir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Jank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Keunecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina Alisa","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofya","family":"Marchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang D.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen","family":"Kulbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Ioana","family":"Braicu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Denkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Darb-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno V.","family":"Sinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3041-694X","authenticated-orcid":false,"given":"Eliane T.","family":"Taube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2023.09.001_bib1","article-title":"Ovary","volume":"vol. 2021","year":"2020"},{"key":"10.1016\/j.humpath.2023.09.001_bib2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2023.09.001_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijc.2910580315","article-title":"Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells","volume":"58","author":"Veatch","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2023.09.001_bib4","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-08-4151","article-title":"Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination","volume":"69","author":"Moss","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2023.09.001_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.593017","article-title":"Deregulation of lipid metabolism: the critical factors in ovarian cancer","volume":"10","author":"Ji","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2023.09.001_bib6","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.18632\/oncotarget.6757","article-title":"Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer","volume":"7","author":"Shao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2023.09.001_bib7","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3892\/or.2012.1638","article-title":"Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer","volume":"27","author":"Wang","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.humpath.2023.09.001_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12032-014-0391-z","article-title":"Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer","volume":"32","author":"Cai","year":"2015","journal-title":"Med Oncol"},{"key":"10.1016\/j.humpath.2023.09.001_bib9","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1038\/s41467-018-04987-y","article-title":"FABP4 as a key determinant of metastatic potential of ovarian cancer","volume":"9","author":"Gharpure","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2023.09.001_bib10","doi-asserted-by":"crossref","first-page":"28889","DOI":"10.1074\/jbc.M102727200","article-title":"The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein","volume":"276","author":"Liu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2023.09.001_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ph14090836","article-title":"LRP1B: a giant lost in cancer translation","volume":"14","author":"Pr\u00edncipe","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.humpath.2023.09.001_bib12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1349-7006.2006.00283.x","article-title":"Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma","volume":"97","author":"Nakagawa","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2023.09.001_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/gcc.20752","article-title":"Aberrant methylation impairs low density lipoprotein receptor-related protein 1B tumor suppressor function in gastric cancer","volume":"49","author":"Lu","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2023.09.001_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/gcc.20746","article-title":"A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene","volume":"49","author":"Kohno","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2023.09.001_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2017.04.010","article-title":"Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells","volume":"357","author":"Wang","year":"2017","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.humpath.2023.09.001_bib16","doi-asserted-by":"crossref","first-page":"68721","DOI":"10.18632\/oncotarget.11897","article-title":"Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member","volume":"7","author":"Beer","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2023.09.001_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/cas.12157","article-title":"Down expression of LRP1B promotes cell migration via RhoA\/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer","volume":"104","author":"Ni","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2023.09.001_bib18","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.7150\/ijbs.56970","article-title":"LRP1B mutation is associated with tumor HPV status and promotes poor disease outcomes with a higher mutation count in HPV-related cervical carcinoma and head & neck squamous cell carcinoma","volume":"17","author":"Cao","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.humpath.2023.09.001_bib19","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.7150\/jca.53124","article-title":"LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma","volume":"12","author":"Liu","year":"2021","journal-title":"J Cancer"},{"key":"10.1016\/j.humpath.2023.09.001_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1522250","article-title":"Correlation between LRP1B mutations and tumor mutation burden in gastric cancer","volume":"2021","author":"Hu","year":"2021","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.humpath.2023.09.001_bib21","first-page":"1","article-title":"Analysis of copy number alterations in bladder cancer stem cells revealed a prognostic role of LRP1B","author":"Conconi","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.humpath.2023.09.001_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jns.2015.09.345","article-title":"LRP1B deletion is associated with poor outcome for glioblastoma patients","volume":"358","author":"Tabouret","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.humpath.2023.09.001_bib23","series-title":"World Health Organization Classification of Soft Tissue and Bone Tumours","year":"2020"},{"key":"10.1016\/j.humpath.2023.09.001_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.humpath.2023.09.001_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.humpath.2023.09.001_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2023.09.001_bib27","unstructured":"S3-Leitlinie Diagnostik, Therapie und Nachsorge maligner Ovarialtumoren. https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Ovarialkarzinom\/Version_5\/LL_Ovarialkarzinom_Langversion_5.0.pdf."},{"key":"10.1016\/j.humpath.2023.09.001_bib28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000517372","article-title":"LRP1B expression as a putative predictor of response to pegylated liposomal doxorubicin treatment in ovarian cancer","volume":"88","author":"Dion\u00edsio de Sousa","year":"2021","journal-title":"Pathobiology"},{"key":"10.1016\/j.humpath.2023.09.001_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-017-0732-6","article-title":"Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression","volume":"16","author":"Yang","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.humpath.2023.09.001_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13048-023-01239-6","article-title":"High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma","volume":"16","author":"Jank","year":"2023","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.humpath.2023.09.001_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0090-8258(02)00015-X","article-title":"beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma","volume":"88","author":"Lee","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2023.09.001_bib32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","article-title":"Buchsbaum DJ: the Wnt\/\u03b2-catenin pathway in ovarian cancer: a review","volume":"131","author":"Arend","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2023.09.001_bib33","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3389\/fimmu.2019.01113","article-title":"Association of LRP1B mutation with tumor mutation burden and outcomes in melanoma and non-small cell lung cancer patients treated with immune check-point blockades","volume":"10","author":"Chen","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.humpath.2023.09.001_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001792","article-title":"LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types","volume":"9","author":"Brown","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.humpath.2023.09.001_bib35","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1158\/0008-5472.CAN-12-0203","article-title":"LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin","volume":"72","author":"Cowin","year":"2012","journal-title":"Cancer Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723001867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723001867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:42:11Z","timestamp":1758645731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817723001867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":35,"alternative-id":["S0046817723001867"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2023.09.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LRP1B\u2014a prognostic marker in tubo-ovarian high-grade serous carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}